Skip to main content
NCBI home page
Mediators of Inflammation logoLink to Mediators of Inflammation
. 2000;9(3-4):175–179. doi: 10.1080/09629350020008691

Eotaxin in serum of patients with asthma or chronic obstructive pulmonary disease: relationship with eosinophil cationic protein and lung function.

K Jahnz-Ró yk 1, T Plusa 1, J Mierzejewska 1
PMCID: PMC1781764  PMID: 11132775

Abstract

This study was undertaken to investigate the correlation between the serum ECP and the serum eotaxin level, and disease activity as evaluated with pulmonary function in patients with asthma or chronic obstructive pulmonary disease (COPD). 20 patients with stable asthma and 15 patients with COPD, and 15 subjects of the control group took part in this study. The analysis of ECP was performed according to the manufacturer's directions (Pharmacia Diagnostics AB, Uppsala, Sweden). The ELISA test was used to measure eotaxin levels in sserum (kits from R&D, USA). The levels of ECP were 16.9+/-6.3 microg/L in patients with asthma, 15.1+/-9.3 microg/L in patients with COPD and 11.8+/-6.2 microg/L in the control group (P<0.05). There was no significant difference in the asthma ECP level compared with the ECP level in COPD. There was a significant difference between the ECP plasma level in asthma compared with the ECP plasma level in the control group (p<0.05). The levels of eotaxin were 175.8+/-49.3 pg/mL in the control group. There was a correlation of ECP and the eotaxin level in asthma patients (r=+0.5, p<0.05). The percentage fall in FEV1 correlated with eotaxin level in asthma (r=-0.3, p<0.05) and with the eotaxin level in COPD (r=-0.5, p<0.05). Serum outcomes of eotaxin and ECP levels appear to be a useful indicator of atopic asthma, and might provide complementary data disease monitoring. Therefore, further investigations are required to clarify whether serum eotaxin measurements have a role in the clinical evaluation in COPD.

Full Text

The Full Text of this article is available as a PDF (157.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Collins P. D., Marleau S., Griffiths-Johnson D. A., Jose P. J., Williams T. J. Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo. J Exp Med. 1995 Oct 1;182(4):1169–1174. doi: 10.1084/jem.182.4.1169. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Fujimoto K., Kubo K., Yamamoto H., Yamaguchi S., Matsuzawa Y. Eosinophilic inflammation in the airway is related to glucocorticoid reversibility in patients with pulmonary emphysema. Chest. 1999 Mar;115(3):697–702. doi: 10.1378/chest.115.3.697. [DOI] [PubMed] [Google Scholar]
  3. Gonzalo J. A., Lloyd C. M., Wen D., Albar J. P., Wells T. N., Proudfoot A., Martinez-A C., Dorf M., Bjerke T., Coyle A. J. The coordinated action of CC chemokines in the lung orchestrates allergic inflammation and airway hyperresponsiveness. J Exp Med. 1998 Jul 6;188(1):157–167. doi: 10.1084/jem.188.1.157. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Griffin E., Håkansson L., Formgren H., Jörgensen K., Peterson C., Venge P. Blood eosinophil number and activity in relation to lung function in patients with asthma and with eosinophilia. J Allergy Clin Immunol. 1991 Feb;87(2):548–557. doi: 10.1016/0091-6749(91)90014-f. [DOI] [PubMed] [Google Scholar]
  5. Jeffery P. K. Differences and similarities between chronic obstructive pulmonary disease and asthma. Clin Exp Allergy. 1999 Jun;29 (Suppl 2):14–26. [PubMed] [Google Scholar]
  6. Jinquan T., Quan S., Feili G., Larsen C. G., Thestrup-Pedersen K. Eotaxin activates T cells to chemotaxis and adhesion only if induced to express CCR3 by IL-2 together with IL-4. J Immunol. 1999 Apr 1;162(7):4285–4292. [PubMed] [Google Scholar]
  7. Jose P. J., Griffiths-Johnson D. A., Collins P. D., Walsh D. T., Moqbel R., Totty N. F., Truong O., Hsuan J. J., Williams T. J. Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation. J Exp Med. 1994 Mar 1;179(3):881–887. doi: 10.1084/jem.179.3.881. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Lamkhioued B., Renzi P. M., Abi-Younes S., Garcia-Zepada E. A., Allakhverdi Z., Ghaffar O., Rothenberg M. D., Luster A. D., Hamid Q. Increased expression of eotaxin in bronchoalveolar lavage and airways of asthmatics contributes to the chemotaxis of eosinophils to the site of inflammation. J Immunol. 1997 Nov 1;159(9):4593–4601. [PubMed] [Google Scholar]
  9. Lilly C. M., Woodruff P. G., Camargo C. A., Jr, Nakamura H., Drazen J. M., Nadel E. S., Hanrahan J. P. Elevated plasma eotaxin levels in patients with acute asthma. J Allergy Clin Immunol. 1999 Oct;104(4 Pt 1):786–790. doi: 10.1016/s0091-6749(99)70288-5. [DOI] [PubMed] [Google Scholar]
  10. Luster A. D., Rothenberg M. E. Role of the monocyte chemoattractant protein and eotaxin subfamily of chemokines in allergic inflammation. J Leukoc Biol. 1997 Nov;62(5):620–633. doi: 10.1002/jlb.62.5.620. [DOI] [PubMed] [Google Scholar]
  11. Morita A., Shimosako K., Kikuoka S., Taniguchi Y., Kitaura M., Sasakura K., Tamaki M., Tsuji T., Teraoka H., Yoshie O. Development of a sensitive enzyme-linked immunosorbent assay for eotaxin and measurement of its levels in human blood. J Immunol Methods. 1999 Jun 24;226(1-2):159–167. doi: 10.1016/s0022-1759(99)00066-6. [DOI] [PubMed] [Google Scholar]
  12. Niimi A., Amitani R., Suzuki K., Tanaka E., Murayama T., Kuze F. Serum eosinophil cationic protein as a marker of eosinophilic inflammation in asthma. Clin Exp Allergy. 1998 Feb;28(2):233–240. doi: 10.1046/j.1365-2222.1998.00217.x. [DOI] [PubMed] [Google Scholar]
  13. Pesci A., Balbi B., Majori M., Cacciani G., Bertacco S., Alciato P., Donner C. F. Inflammatory cells and mediators in bronchial lavage of patients with chronic obstructive pulmonary disease. Eur Respir J. 1998 Aug;12(2):380–386. doi: 10.1183/09031936.98.12020380. [DOI] [PubMed] [Google Scholar]
  14. Saetta M., Di Stefano A., Maestrelli P., Turato G., Mapp C. E., Pieno M., Zanguochi G., Del Prete G., Fabbri L. M. Airway eosinophilia and expression of interleukin-5 protein in asthma and in exacerbations of chronic bronchitis. Clin Exp Allergy. 1996 Jul;26(7):766–774. [PubMed] [Google Scholar]
  15. Saetta M., Di Stefano A., Maestrelli P., Turato G., Ruggieri M. P., Roggeri A., Calcagni P., Mapp C. E., Ciaccia A., Fabbri L. M. Airway eosinophilia in chronic bronchitis during exacerbations. Am J Respir Crit Care Med. 1994 Dec;150(6 Pt 1):1646–1652. doi: 10.1164/ajrccm.150.6.7952628. [DOI] [PubMed] [Google Scholar]
  16. Scheerens J., Folkerts G., Van Der Linde H., Sterk P. J., Conroy D. M., Williams T. J., Nijkamp F. P. Eotaxin levels and eosinophils in guinea pig broncho-alveolar lavage fluid are increased at the onset of a viral respiratory infection. Clin Exp Allergy. 1999 Jun;29 (Suppl 2):74–77. doi: 10.1046/j.1365-2222.1999.00012.x. [DOI] [PubMed] [Google Scholar]
  17. Venge P., Henriksen J., Dahl R. Eosinophils in exercise-induced asthma. J Allergy Clin Immunol. 1991 Nov;88(5):699–704. doi: 10.1016/0091-6749(91)90175-n. [DOI] [PubMed] [Google Scholar]
  18. Venge P. Serum measurements of eosinophil cationic protein (ECP) in bronchial asthma. Clin Exp Allergy. 1993 Jun;23 (Suppl 2):3-7, discussion 15-22. doi: 10.1111/j.1365-2222.1993.tb00372.x. [DOI] [PubMed] [Google Scholar]
  19. White J. R., Imburgia C., Dul E., Appelbaum E., O'Donnell K., O'Shannessy D. J., Brawner M., Fornwald J., Adamou J., Elshourbagy N. A. Cloning and functional characterization of a novel human CC chemokine that binds to the CCR3 receptor and activates human eosinophils. J Leukoc Biol. 1997 Nov;62(5):667–675. doi: 10.1002/jlb.62.5.667. [DOI] [PubMed] [Google Scholar]
  20. Yamada H., Hirai K., Miyamasu M., Iikura M., Misaki Y., Shoji S., Takaishi T., Kasahara T., Morita Y., Ito K. Eotaxin is a potent chemotaxin for human basophils. Biochem Biophys Res Commun. 1997 Feb 13;231(2):365–368. doi: 10.1006/bbrc.1997.6100. [DOI] [PubMed] [Google Scholar]
  21. Zeibecoglou K., Macfarlane A. J., Ying S., Meng Q., Pavord I., Barnes N. C., Robinson D. S., Kay A. B. Increases in eotaxin-positive cells in induced sputum from atopic asthmatic subjects after inhalational allergen challenge. Allergy. 1999 Jul;54(7):730–735. doi: 10.1034/j.1398-9995.1999.00058.x. [DOI] [PubMed] [Google Scholar]
  22. de Blay F., Purohit A., Stenger R., Gries P., Hamberger C., David B., Frossard N., Pauli G. Serum eosinophil cationic protein measurements in the management of perennial and periodic asthma: a prospective study. Eur Respir J. 1998 Mar;11(3):594–598. [PubMed] [Google Scholar]

Articles from Mediators of Inflammation are provided here courtesy of Wiley

RESOURCES